FGF10 and gastric adenocarcinoma: Interrogation of most recent cBioPortal data suggests this could be an underestimate, with FGF10 amplifications reported in 5.7% of stomach adenocarcinoma cases (Cerami et al., 2012; Gao et al., 2013).